Watson Pharmaceuticals Inc

Type: Company
Name: Watson Pharmaceuticals Inc
First reported 18 hours ago - Updated 18 hours ago - 1 reports

Is This The Best Health Care Stock To Own Right Now?

Although investing is about making money, I've noticed that losses are what really stick out in people's minds.If their advisor tells them their portfolio is up say 7% this year, they'll come back with something like "Yeah, but if such-and-such investment ... [Published StreetAuthority - 18 hours ago]
First reported Jul 22 2014 - Updated Jul 23 2014 - 1 reports

Top court rules on birth control mandate

The U.S. Supreme Court on Monday ruled that business owners can object on religious grounds to a provision of President Barack Obama's healthcare law that requires closely held private companies to provide health insurance that covers birth control.In ... [Published Hartford Courant - Jul 22 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

Deutsche Bank Initiates Coverage on Actavis plc (ACT)

Equities research analysts at Deutsche Bank initiated coverage on shares of Actavis plc (NYSE:ACT)Shares of Actavis plc (NYSE:ACT) traded up 0.11% during mid-day trading on Tuesday, hitting $216.37. 1,478,383 shares of the company’s stock traded hands. ... [Published American Banking News - Stock Ratings - Jul 22 2014]
First reported Jul 14 2014 - Updated Jul 14 2014 - 1 reports

Actavis Fuels Growth With Acquisitions, New Generics

Actavis (ACT) has kept busy on the merger and acquisition trail the past couple of years. Since closing its acquisition of Forest Laboratories on July 2, when new CEO (and former Forest chief) Brenton Saunders took the helm, Actavis has completed a $1.1 ... [Published Town Hall - Jul 14 2014]
First reported Jul 03 2014 - Updated Jul 03 2014 - 1 reports

Human Reproductive Technologies Market Will Reach USD 27.1 Billion Globally in 2019: Transparency Market Research

According to a new market report “Human Reproductive Technologies Market - Global Industry Analysis, Size, Procedures, Share, Growth, Trends and Forecast, 2013 – 2019,” the global market for human reproductive technologies was valued at USD 23.0 billion ... [Published MyNewsDesk - Jul 03 2014]
First reported Jun 30 2014 - Updated Jul 01 2014 - 1 reports

U.S. justices uphold firms' religious objections to contraception

9:26 a.m. CDTBy Lawrence HurleyWASHINGTON (Reuters) - The U.S. Supreme Court on Monday ruled that business owners can object on religious grounds to a provision of President Barack Obama's healthcare law that requires closely held private companies to ... [Published KFGO News - Jun 30 2014]
First reported Jun 26 2014 - Updated Jun 26 2014 - 1 reports

JHL Biotech Closes $35 Million Series B Financing

By a News Reporter-Staff News Editor at Pharma Business Week -- JHL Biotech, Inc. , an emerging biopharmaceutical company, announced that it has closed a Series B financing round of $35 million , led by new investors Milestone Capital and a consortium ... [Published HispanicBusiness.com - Jun 26 2014]
First reported Jun 23 2014 - Updated Jun 23 2014 - 2 reports

Actavis plc Receives Average Rating of “Buy” from Brokerages (NYSE:ACT)

Actavis plc (NYSE:ACT) has earned a consensus rating of "Buy" from the twenty-two ratings firms that are covering the company, . Four research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong ... [Published American Banking News - Jun 23 2014]
First reported Jun 19 2014 - Updated Jun 20 2014 - 3 reports

JHL Biotech closes USD35m series B financing

JHL Biotech has closed a Series B financing round of USD35 million, led by new investors Milestone Capital and a consortium of Taiwan venture capitalists and individuals.The consortium includes President International Development Corp, Fubon Financial ... [Published Private Equity Wire - Jun 20 2014]
First reported Jun 16 2014 - Updated Jun 17 2014 - 2 reports

Aerie Pharmaceuticals Names Craig R. Skenes as Vice President, Business Development

BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C. & NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class ... [Published Citybizlist - Jun 17 2014]
First reported May 12 2014 - Updated May 12 2014 - 1 reports

NEXT CHOICE ONE DOSE (Levonorgestrel) Tablet [Watson Pharma, Inc.]

First reported May 01 2014 - Updated May 01 2014 - 1 reports

NORCO (Hydrocodone Bitartate And Acetaminophen) Tablet [Watson Pharma, Inc.]

Quotes

If their advisor tells them their portfolio is up say 7% this year, they'll come back with something like "Yeah, but if such-and-such investment hadn't tanked, I'd be up 10%."
"In a decision of startling breadth, the court holds that commercial enterprises, including corporations, along with partnerships and sole proprietorships, can opt out of any law ... they judge incompatible with their sincerely held religious beliefs" she wrote
When asked in a 2011 "Globes" interview whether Perrigo was a likely target for acquisition, Perrigo CEO Joseph Papa answered, "The answer always has to be yes, but we'll wait and see. Up until now, we've been the ones making acquisitions, and I believe we'll go on the same way."
The government's accommodation is "less restrictive than requiring employers to fund contraceptive methods that violate their religious beliefs" Alito wrote...

More Content

All (51) | News (37) | Reports (0) | Blogs (10) | Audio/Video (0) | Fact Sheets (4) | Press Releases (0)
sort by: Date | Relevance
Is This The Best Health Care Stock To Own Right... [Published StreetAuthority - 18 hours ago]
Deutsche Bank Initiates Coverage on Actavis plc... [Published American Banking News - Stock Ratings - Jul 22 2014]
Top court rules on birth control mandate [Published Hartford Courant - Jul 22 2014]
Pre-Filled Syringes Market (2nd Edition), 2014 ... [Published RCL Advisors - Jul 21 2014]
Global Women's Health Market : 2014-2018 [Published MarketResearch.com - Jul 16 2014]
Actavis Fuels Growth With Acquisitions, New Gen... [Published Town Hall - Jul 14 2014]
Perrigo up for sale [Published Globes - Jul 14 2014]
Human Reproductive Technologies Market Will Rea... [Published MyNewsDesk - Jul 03 2014]
UPDATE 3-U.S. justices uphold firms' religious ... [Published Reuters - Jun 30 2014]
U.S. justices uphold firms' religious objection... [Published KFGO News - Jun 30 2014]
Canaccord Genuity Initiates Coverage on Actavis... [Published American Banking News - Jun 27 2014]
World Market for Pain Management Drugs and Devi... [Published Individual.com - Jun 26 2014]
JHL Biotech Closes $35 Million Series B Financing [Published HispanicBusiness.com - Jun 26 2014]
AERIE PHARMACEUTICALS : Names Craig R. Skenes a... [Published 4 Traders - Jun 26 2014]
Actavis plc Receives Average Rating of “Buy” fr... [Published American Banking News - Jun 23 2014]
Actavis plc Given “Overweight” Rating at JPMorg... [Published American Banking News - Jun 23 2014]
China's JHL Biotech raises $35 million [Published Bio Spectrum Asia - Jun 23 2014]
Today’s deals: Battery-powered bus co. raises $... [Published Fortune - Jun 20 2014]
JHL Biotech closes USD35m series B financing [Published Private Equity Wire - Jun 20 2014]
JHL Biotech raises $35 mln Series B funding [Published PE Hub Blog - Jun 20 2014]
JHL Biotech Closes $35 Million Series B Financing [Published Wall Street Business Network - Jun 19 2014]
Actavis plc’s “Overweight” Rating Reaffirmed at... [Published American Banking News - Jun 18 2014]
Global generic drugs market revenue forecast to... [Published PR inside - Jun 17 2014]
Aerie Pharmaceuticals Names Craig R. Skenes as ... [Published Citybizlist - Jun 17 2014]
In pair of patent cases, District Court splits ... [Published Lexology - Jun 17 2014]
Aerie Pharmaceuticals Names Craig R. Skenes as ... [Published BusinessWeek - Jun 16 2014]
Global Ophthalmic Drugs Market Worth $9.7bn by ... [Published PRWeb - Jun 04 2014]
Model N Recognized for Innovation by San Franci... [Published PRWeb - May 27 2014]
Global Human Reproductive Technologies Market: ... [Published PRWeb - May 21 2014]
NEXT CHOICE ONE DOSE (Levonorgestrel) Tablet [W... [Published DailyMed Drug Label Updates for the last seven ... - May 12 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
JHL Biotech raises $35 mln Series B funding [Published PE Hub Blog - Jun 20 2014]
Milestone Capital has led a $35 million Series B funding in JHL Biotech, Inc. , a biopharmaceutical company. Milestone was joined by a consortium of venture capitalists and individuals, including President International Corp. , Fubon Financial Holdings ...
NEXT CHOICE ONE DOSE (Levonorgestrel) Tablet [W... [Published DailyMed Drug Label Updates for the last seven ... - May 12 2014]
Updated Date: May 12, 2014 EST ...
NORCO (Hydrocodone Bitartate And Acetaminophen)... [Published DailyMed Drug Label Updates for the last seven ... - May 01 2014]
Updated Date: Apr 30, 2014 EST ...
NORCO (Hydrocodone Bitartate And Acetaminophen)... [Published DailyMed Drug Label Updates for the last seven ... - Apr 30 2014]
Updated Date: Apr 30, 2014 EST ...
RECLIPSEN (Desogestrel And Ethinyl Estradiol) K... [Published DailyMed Drug Label Updates for the last seven ... - Apr 24 2014]
Updated Date: Apr 16, 2014 EST ...
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.